Sanofi-Genzyme takeover talks in final stretch
(Reuters)
Reuters - France's Sanofi-Aventis was closing in on a roughly $20 billion deal to buy U.S. biotech group Genzyme while pausing to take a final look at the books, sources familiar with the matter said.
Keine Kommentare:
Kommentar veröffentlichen